Gaby Hobbs
@GabyHobbs
Followers
1K
Following
6K
Media
58
Statuses
756
Clinical director of leukemia at MGH. MPN researcher. Associate Professor, Harvard Med School. Love teaching, mentoring, collaborating. Runner, mom, 🇲🇽
MGH
Joined December 2011
"People may think physicians become hardened, but the longer you do this, the more you understand what lies ahead for your patients" Gabriela Hobbs said in our Pathways & Perspectives @MassGeneralNews
https://t.co/nOku6SRozY
0
1
16
We’re close to @AHAScience #AHA25. Excited to present our work on the CV implications of PH and hemodynamic phenotypes in patients with #MPNsm. Looking forward to catching up with old friends and network with new ones! #cardioonc #hemodynamics
@GabyHobbs @datsunian
0
2
11
Honored to share that my abstract has been accepted for presentation at the 2025 ASH Annual Meeting 🎉 We examined the clinical characteristics and outcomes of myelofibrosis patients with the rare MPL mutation. Excited to attend #ASH25 with mentor Dr.@GabyHobbs
#Hematology #MPN
1
2
10
Looking forward to presenting at this conference!
*Announcing* #NashvilleHeme26 registration is now live! Join chairs, Drs. @drjoannarhodes1, @BerdejaJesus, and @KuykendallMd and 60+ hematology thought leaders in Nashville, TN on February 26-28, 2026! Don't miss this 2-day CE-accredited conference to stay up-to-date on the
0
1
9
congrats to @andrewthepalmer @Anand_88_Patel on their @BloodCancerJnl publication focusing on disparities in myelofibrosis outcomes! Other program member authors include @myeloidmalig @DrWendyStock
https://t.co/jE3C0dO7KQ
0
3
17
In this editor’s special episode, @GabyHobbs, of @MassGeneralNews, joins the program to discuss the most promising developments in myeloproliferative neoplasms presented at recent scientific meetings. 🎧 Listen here! https://t.co/QwUyQTQx6n
0
2
5
It’s here! The 2026 Nashville Hematology Conference agenda is now LIVE! 📍 Join conference chairs Drs. @drjoannarhodes1, @BerdejaJesus, and @KuykendallMd and 60+ experts on February 26–28 in Nashville, TN for 2 packed days of CE-accredited education. REMINDER! Final week to
0
5
9
Amazing work as always @LeivaOrly!!
Excited to share that we have 4 abstracts accepted at #ASH25 @ASH_hematology. I might be an intv cards in the making, but heme runs in my blood (literally). Looking forward to my 9th ASH! Thanks to @GabyHobbs for her support since day 1! #cardioonc #cardioheme See yall in Orlando
0
0
2
CONGRESS | #SOHO2025 | PRESENTATION Gabriela Hobbs @MassGeneralNews discusses novel therapies in development for treatment of #PolycythemiaVera, including modulators of hepcidin-ferroportin, bomedemstat, givinostat, and novel JAKis, and in #EssentialThrombocythemia, including
0
1
4
Wonderful meeting @SocietyofHemOnc thank you for inviting me to talk about novel MPN therapies along with Dr. Mascarenhas. #mpnsm Wonderful to meet with mentees Dr. Yu-Han Chen.
1
4
28
🚨NEW: Chelsea Clinton, daughter of Bill and Hillary Clinton, is strongly considering a run for Congress in New York to replace retiring Rep. Jerry Nadler. RETWEET if you would support @ChelseaClinton for Congress!
4K
6K
30K
#MPNs affect 300,000+ in the U.S. — yet still fly under the radar. This #BloodCancerAwarenessMonth, help bridge the gap. 💬 Reply with your MPN type 🔁 RT to raise awareness 📖 Share your journey Every voice helps change the story. #MPNs #BCAM2025
5
6
19
👉⭐️Truly thrilled to see this in press- Rux-before, during, after-HCT for MF = very low GVHD and excellent PFS/OS. Thank you to all the sites, PIs, Incyte for supporting this and most of all our patients! JCO OA 😀 https://t.co/4PmiFvLVmM
#MPNSM #MGH
ascopubs.org
PURPOSEWe conducted a phase II, multicenter trial (ClinicalTrials.gov identifier: NCT03427866) investigating ruxolitinib administration before, during, and after allogeneic hematopoietic cell...
8
16
68
#freedc I returned from the wedding of our daughter to find the city where I have lived for the last 3 years in the midst of a military takeover. The military policing Americans. This is a danger for everyone in our country. Now is the moment to turn out in protest.
89
335
1K
🏃♀️The MGH 5K is around the corner! 🏃♀️ If you're in Boston 9/14 please join the MGH Leukemia Team or join us by supporting our mission and thank you 😀 https://t.co/uHK5YQa7Ld
because.massgeneral.org
MGH Leukemia Team, running to raise funds for leukemia research!
0
0
0
👉👉👉Delighted to share our brand new MPN debate & article in @ASHClinicalNews @ASH_hematology | @GabyHobbs & @doctorpemm 🙏 @AaronGerds @ASHClinicalNews
#MPNSM @MPN_Hub @MPN_RF @mpdrc @MpncoD @TheIACH @PatientPower @VJHemOnc
https://t.co/SBv7KXKroE
0
10
41
👇🏾 Incredibly harmful for our cancer patients who rely on novel clinical trials with new drugs that can be potentially effective against their disease.
0
9
17
👉👉👉Efficacy of a novel #BCL-xL degrader, #DT2216, in preclinical models of #JAK2-mutated post-MPN AML | @BloodPortfolio | @ASH_hematology | @mkonople @doctorpemm #MPNSM #leusm
ashpublications.org
Key PointsPost-MPN AML cells exhibit BCL-xL dependence.DT2216, a BCL-xL–specific degrader, exhibits a durable antileukemic effect in preclinical models of
0
4
24
Quality over quantity of life!! Out in @JCO_ASCO a prospective trial finding early palliative care during stem cell transplant isn’t just supportive... it’s transformative!! Better quality of life, less depression, mental health benefits lasting up to 6 months after treatment.
2
16
58